Giulia M. Perrone
Bari, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Structural basis of ligand selectivity in FAD/NAD(P)H-dependent dehydrogenases: insights from trypanothione reductase and type II NADH dehydrogenase.
Journal: Protein science : a publication of the Protein Society
Published: March 28, 2026
Single Cancer Center Experience on Patient Blood Management Eligibility in Oncological Surgery.
Journal: Journal of clinical medicine
Published: February 10, 2026
Discovery of chalcone derivatives as antileishmanial agents: phenotypic screening, exploratory docking and enzymatic assays on trypanothione reductase and related flavoproteins.
Journal: Bioorganic chemistry
Published: September 26, 2025
Sequence/structural/functional relationships between Ganoderma fungal immunomodulatory proteins (gFIPs) and proteins involved in the modulation of immune response.
Journal: Journal of structural biology
Published: April 26, 2025
Three-Dimensional Modeling of Camelus dromedarius T Cell Receptor Gamma (TRG)_Delta (TRD)/CD1D Complex Reveals Different Binding Interactions Depending on the TRD CDR3 Length.
Journal: Antibodies (Basel, Switzerland)
Published: February 18, 2025
A Journey Through Myeloma Evolution: From the Normal Plasma Cell to Disease Complexity.
Journal: HemaSphere
Published: June 18, 2020
HIF-1α inhibition blocks the cross talk between multiple myeloma plasma cells and tumor microenvironment.
Journal: Experimental cell research
Published: May 09, 2014
Hypoxia inducible factor-1 alpha as a therapeutic target in multiple myeloma.
Journal: Oncotarget
Published: April 16, 2014
Autoimmune diseases during treatment with immunomodulatory drugs in multiple myeloma: selective occurrence after lenalidomide.
Journal: Leukemia & lymphoma
Published: April 16, 2014
Autologous stem cell transplantation for T-cell lymphomas.
Journal: Seminars in hematology
Published: January 29, 2014
Current state of art for transplantation paradigms in peripheral T-cell lymphomas.
Journal: Expert review of hematology
Published: September 03, 2013
Bortezomib and dexamethasone as salvage therapy in patients with relapsed/refractory multiple myeloma: analysis of long-term clinical outcomes.
Journal: Annals of hematology
Published: March 13, 2013
Last Updated: 09/26/2026